A test system has been developed by Russian scientists that can identify approximately 2,500 hereditary diseases in newborns within the first days of their lives. Prime Minister Mikhail Mishustin spoke about this at a strategic session dedicated to socio-economic development.
“We are creating new innovative products to improve people’s health. We are also developing drugs based on cellular technologies,” the prime minister noted. “One test system for newborns has been registered, and it is capable of identifying about 2.5 thousand hereditary diseases in the first days of a baby’s life and, This means it’s time to help him.”
Mishustin stated that the clinical trials for tissue engineering products to treat joint diseases and fractures are nearing completion. The prime minister emphasized that a broad spectrum of patients will benefit from this therapy. He expressed hope that specialists and scientists will continue to develop increasingly beneficial products.
